Erik Roelofs

7.6k citations

43 papers · 4.7k indexed · 1 hit paper · h-index 16

Radiology, Nuclear Medicine and Imaging top 0.2%
Pulmonary and Respiratory Medicine top 1%
Biomedical Engineering top 5%
Oncology top 5%
Artificial Intelligence top 2%

Co-authors: Philippe Lambin André Dekker Wouter van Elmpt Ralph T. H. Leijenaar Seán Walsh Johan van Soest Tim Lustberg Aniek J.G. Even
Topics: Advanced Radiotherapy Techniques (22 papers)Radiation Therapy and Dosimetry (13 papers)Radiomics and Machine Learning in Medical Imaging (9 papers)
Cited by: Radiology, Nuclear Medicine and Imaging Health Informatics Pulmonary and Respiratory Medicine
Journals: Nature Reviews Clinical Oncology Medical Physics Radiotherapy and Oncology
Partner nations: Netherlands United States Germany

In The Last Decade

Erik Roelofs

37 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radiomics: the bridge between medical imaging and personalized medicine

2017 3.7k citations Philippe Lambin, Ralph T. H. Leijenaar et al. Nature Reviews Clinical Oncology profile →

Peers

Countries citing papers authored by Erik Roelofs

Since Specialization

Citations

This map shows the geographic impact of Erik Roelofs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Roelofs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Roelofs more than expected).

Fields of papers citing papers by Erik Roelofs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Roelofs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Roelofs. The network helps show where Erik Roelofs may publish in the future.

Co-authorship network of co-authors of Erik Roelofs

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Roelofs. A scholar is included among the top collaborators of Erik Roelofs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Roelofs. Erik Roelofs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The impact of organ motion and the appliance of mitigation strategies on the effectiveness of hypoxia-guided proton therapy for non-small cell lung cancer 2022 ·Radiotherapy and Oncology ·(unknown),Antony Lomax,(unknown),Sairos Safai,(unknown),Erik Roelofs,Aniek J.G. Even,Damien C. Weber,Giovanni Fattori	5
2	Performance and usability evaluation of a mobile health data capture application in clinical cancer trials follow-up 2022 ·Technical Innovations & Patient Support in Radiation Oncology ·(unknown),(unknown),(unknown),(unknown),Ruud Houben,Daniëlle B. P. Eekers,Erik Roelofs	3
3	The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset 2021 ·Clinical and Translational Radiation Oncology ·(unknown),Erik Roelofs,(unknown),Inge Compter,Yvonne L.B. Klaver,Robert Jan Smeenk,Geert O. Janssens,Johannes H.A.M. Kaanders,Raquel Dávila Fajardo,Foppe Oldenburger,Dirk De Ruysscher,Esther G.C. Troost,Daniëlle B. P. Eekers	2
4	Development of single-session driving simulator-based and computer-based training for at-risk older drivers 2019 ·Educational Gerontology ·(unknown),Erik Roelofs,Ariane Cuenen,Kris Brijs,Tom Brijs,Ellen M.M. Jongen	7
5	EPTN consensus-based guideline for the tolerance dose per fraction of organs at risk in the brain 2018 ·Daniëlle B. P. Eekers,Maarten Lambrecht,(unknown),Ans Swinnen,(unknown),Erik Roelofs,(unknown)	4
6	Photons, protons or carbon ions for stage I non-small cell lung cancer – Results of the multicentric ROCOCO in silico study 2018 ·Radiotherapy and Oncology ·(unknown),Erik Roelofs,Charles B. Simone,(unknown),(unknown),J. van der Stoep,Wim Dries,(unknown),Stephen Avery,(unknown),Nicolas Jansen,Urszula Jelen,Timothy D. Solberg,Dirk De Ruysscher,Esther G.C. Troost	30
7	Radiomics: the bridge between medical imaging and personalized medicinebreakdown → 2017 ·Nature Reviews Clinical Oncology ·Philippe Lambin,Ralph T. H. Leijenaar,Timo M. Deist,Jurgen Peerlings,Evelyn E.C. de Jong,Janita E. van Timmeren,Sebastian Sanduleanu,Ruben T. H. M. Larue,Aniek J.G. Even,Arthur Jochems,Yvonka van Wijk,Henry C. Woodruff,Johan van Soest,Tim Lustberg,Erik Roelofs,Wouter van Elmpt,André Dekker,Felix M. Mottaghy,Joachim E. Wildberger,Seán Walsh	3729
8	Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial 2016 ·Radiotherapy and Oncology ·Daniëlle B. P. Eekers,Erik Roelofs,Urszula Jelen,Maura Kirk,(unknown),(unknown),Peter H. Ahn,Geert O. Janssens,Frank Hoebers,(unknown),Timothy D. Solberg,Seán Walsh,Esther G.C. Troost,Johannes H.A.M. Kaanders,Philippe Lambin	49
9	A validated tumor control probability model based on a meta‐analysis of low, intermediate, and high‐risk prostate cancer patients treated by photon, proton, or carbon‐ion radiotherapy 2016 ·Medical Physics ·Seán Walsh,Erik Roelofs,Peter Kuess,Philippe Lambin,Bleddyn Jones,Dietmar Georg,Frank Verhaegen	12
10	Development and evaluation of an online three-level proton vs photon decision support prototype for head and neck cancer – Comparison of dose, toxicity and cost-effectiveness 2016 ·Radiotherapy and Oncology ·Qing Cheng,Erik Roelofs,Bram Ramaekers,Daniëlle B. P. Eekers,Johan van Soest,Tim Lustberg,(unknown),Frank Hoebers,Hans Paul van der Laan,Erik W. Korevaar,André Dekker,Johannes A. Langendijk,Philippe Lambin	51
11	EP-1480: Development and validation of a proton decision support system comparing dose, toxicity and cost-effectiveness 2015 ·Radiotherapy and Oncology ·Qing Cheng,Erik Roelofs,Bram Ramaekers,Daniëlle B. P. Eekers,Johan van Soest,(unknown),(unknown),André Dekker,Philippe Lambin	2
12	Particle Therapy for Non-Small Cell Lung Tumors: Where Do We Stand? A Systematic Review of the Literature 2014 ·Frontiers in Oncology ·(unknown),Erik Roelofs,Timothy D. Solberg,Liyong Lin,Charles B. Simone,Annika Jakobi,Christian Richter,Philippe Lambin,Esther G.C. Troost	49
13	‘Rapid Learning health care in oncology’ – An approach towards decision support systems enabling customised radiotherapy’ 2013 ·Radiotherapy and Oncology ·Philippe Lambin,Erik Roelofs,Bart Reymen,Emmanuel Rios Velazquez,Jeroen Buijsen,Catharina M.L. Zegers,Sara Carvalho,Ralph T. H. Leijenaar,Georgi Nalbantov,Cary Oberije,Michael S. Marshall,Frank Hoebers,Esther G.C. Troost,Ruud G.P.M. van Stiphout,Wouter van Elmpt,Trudy van der Weijden,Liesbeth Boersma,Vincenzo Valentini,André Dekker	136
14	Benefits of a clinical data warehouse with data mining tools to collect data for a radiotherapy trial 2013 ·Radiotherapy and Oncology ·Erik Roelofs,L. Persoon,S. Nijsten,(unknown),André Dekker,Philippe Lambin	45
15	An in silico comparison between margin-based and probabilistic target-planning approaches in head and neck cancer patients 2013 ·Radiotherapy and Oncology ·Davide Fontanarosa,Hans Paul van der Laan,Marnix G. Witte,Georgy Shakirin,Erik Roelofs,Johannes A. Langendijk,Philippe Lambin,Marcel van Herk	14
16	Informatics methods to enable sharing of quantitative imaging research data 2012 ·Magnetic Resonance Imaging ·Mia Levy,John Freymann,Justin Kirby,Andriy Fedorov,Fiona M. Fennessy,Steven A. Eschrich,Anders Berglund,David Fenstermacher,Yongqiang Tan,Xiaotao Guo,Thomas L. Casavant,Bartley Brown,Terry A. Braun,André Dekker,Erik Roelofs,James M. Mountz,Fernando E. Boada,Charles M. Laymon,(unknown),Daniel L. Rubin	13
17	Predicting outcomes in radiation oncology—multifactorial decision support systems 2012 ·Nature Reviews Clinical Oncology ·Philippe Lambin,Ruud G.P.M. van Stiphout,Maud H. W. Starmans,(unknown),Georgi Nalbantov,Hugo J.W.L. Aerts,Erik Roelofs,Wouter van Elmpt,Paul C. Boutros,Pierluigi Granone,Vincenzo Valentini,Adrian C. Begg,Dirk De Ruysscher,André Dekker	281
18	Results of a Multicentric In Silico Clinical Trial (ROCOCO): Comparing Radiotherapy with Photons and Protons for Non-small Cell Lung Cancer 2011 ·Journal of Thoracic Oncology ·Erik Roelofs,Martijn Engelsman,C. Rasch,L. Persoon,(unknown),Dirk De Ruysscher,Frank Verhaegen,Madelon Pijls-Johannesma,Philippe Lambin	76
19	Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: First evaluation of quality of radiotherapy planning 2010 ·Radiotherapy and Oncology ·E. Musat,Erik Roelofs,R. Bar-Deroma,Paul Fenton,Ákos Gulybán,Laurence Collette,Roger Stupp,Damien C. Weber,J.B. Davis,Edwin Aird,Brigitta G. Baumert	15
20	Design of and technical challenges involved in a framework for multicentric radiotherapy treatment planning studies 2010 ·Radiotherapy and Oncology ·Erik Roelofs,L. Persoon,(unknown),Frank Verhaegen,Dirk De Ruysscher,M. Scholz,Gheorghe Iancu,Martijn Engelsman,C. Rasch,Lambert Zijp,Gert De Meerleer,M. Coghe,Johannes A. Langendijk,Cornelis Schilstra,Madelon Pijls-Johannesma,Philippe Lambin	28

About Erik Roelofs

Erik Roelofs is a scholar working on Radiation, Otorhinolaryngology and Radiology, Nuclear Medicine and Imaging, having authored 43 papers that have together received 4.7k indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (22 papers), Radiation Therapy and Dosimetry (13 papers) and Radiomics and Machine Learning in Medical Imaging (9 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (3.9k citations), Health Informatics (198 citations) and Pulmonary and Respiratory Medicine (1.8k citations). Erik Roelofs has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Philippe Lambin, André Dekker, Wouter van Elmpt, Ralph T. H. Leijenaar, Seán Walsh, Johan van Soest, Tim Lustberg, Aniek J.G. Even, Yvonka van Wijk and Joachim E. Wildberger. Their work appears in journals such as Nature Reviews Clinical Oncology, Medical Physics and Radiotherapy and Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact